Yu C, Sheng Y, Yu F, Ni H, Qiu A, Huang Y, et al. Foxm1 haploinsufficiency drives clonal hematopoiesis and promotes a stress-related transition to hematologic malignancy in mice. J Clin Invest. 2023;133: pubmed publisher

Yang S, Hwang S, Kim B, Shin S, Kim M, Jeong S. Fatty acid oxidation facilitates DNA double-strand break repair by promoting PARP1 acetylation. Cell Death Dis. 2023;14:435 pubmed publisher

Concei xe7 xe3 o C, Salgueiro B, Ribeiro P, Raposo M, Moe E. Advances in the expression and purification of human PARP1: A user-friendly protocol. Protein Expr Purif. 2023;211:106336 pubmed publisher

Kim C, Wang X, Jang S, Yu Y. PARP1 inhibitors induce pyroptosis via caspase 3-mediated gasdermin E cleavage. Biochem Biophys Res Commun. 2023;646:78-85 pubmed publisher

Yang F, Chen J, Liu B, Gao G, Sebastian M, Jeter C, et al. SPINDOC binds PARP1 to facilitate PARylation. Nat Commun. 2021;12:6362 pubmed publisher

Sun Y, Chen J, Huang S, Su Y, Wang W, Agama K, et al. PARylation prevents the proteasomal degradation of topoisomerase I DNA-protein crosslinks and induces their deubiquitylation. Nat Commun. 2021;12:5010 pubmed publisher

Kim C, Wang X, Yu Y. PARP1 inhibitors trigger innate immunity via PARP1 trapping-induced DNA damage response. elife. 2020;9: pubmed publisher

Pecoraro A, Carotenuto P, Russo G, Russo A. Ribosomal protein uL3 targets E2F1 and Cyclin D1 in cancer cell response to nucleolar stress. Sci Rep. 2019;9:15431 pubmed publisher

Liszczak G, Diehl K, Dann G, Muir T. Acetylation blocks DNA damage-induced chromatin ADP-ribosylation. Nat Chem Biol. 2018;14:837-840 pubmed publisher